Solventum falls after reporting lower Q3 sales
SOLV•Solventum’s Q3 sales fell 7% to $1.95 billion, while adjusted EPS was $1.45. The company raised its 2026 adjusted EPS range to $7.20-$7.30, and shares fell 7.1% in extended trading.
1. Quarterly results
Solventum reported Q3 sales of $1.95 billion, down 7% and above analysts’ $1.94 billion estimate, and adjusted EPS of $1.45 versus estimates of $1.35. It raised its 2026 adjusted EPS range to $7.20-$7.30 from $7.10-$7.20; shares fell 7.1% in extended trading.
